Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on February 1, 2007

Stroke. 2007
Published online before print February 1, 2007, doi: 10.1161/01.STR.0000258113.67252.fa
A more recent version of this article appeared on March 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/3/1025    most recent
01.STR.0000258113.67252.fav1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Westberg, J. A.
Right arrow Articles by Andersson, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Westberg, J. A.
Right arrow Articles by Andersson, L. C.
Related Collections
Right arrow Animal models of human disease
Right arrow Acute Cerebral Infarction
Right arrow Neuroprotectors
Right arrow Transient Ischemic Attacks

Submitted on October 6, 2006
Accepted on October 23, 2006

Hypoxic Preconditioning Induces Neuroprotective Stanniocalcin-1 in Brain via IL-6 Signaling

Johan A. Westberg PhD; Martina Serlachius MSc; Petri Lankila MSc; Milena Penkowa MD, PhD; Juan Hidalgo PhD; and Leif C. Andersson MD, PhD*

From Department of Pathology (J.A.W., M.S., P.L., L.C.A.), Haartman Institute, University of Helsinki, Helsinki, Finland; HUSLAB (L.C.A.), Helsinki, Finland; the Department of Medical Anatomy-The Panum Institute (M.P.), University of Copenhagen, Copenhagen, Denmark; Department of Cellular Biology (J.H.), Physiology and Immunology, Institute of Neurosciences, Autonomous University of Barcelona, Barcelona, Spain; Department of Oncology and Pathology (L.C.A.), Karolinska Institutet, Stockholm, Sweden.

* To whom correspondence should be addressed. E-mail: Leif.Andersson{at}helsinki.fi.

Background and Purpose--Exposure of animals for a few hours to moderate hypoxia confers relative protection against subsequent ischemic brain damage. This phenomenon, known as hypoxic preconditioning, depends on new RNA and protein synthesis, but its molecular mechanisms are poorly understood. Increased expression of IL-6 is evident, particularly in the lungs of animals subjected to hypoxic preconditioning. Stanniocalcin-1 (STC-1) is a 56-kDa homodimeric glycoprotein originally discovered in bony fish, where it regulates calcium/phosphate homeostasis and protects against toxic hypercalcemia. We originally reported expression of mammalian STC-1 in brain neurons and showed that STC-1 guards neurons against hypercalcemic and hypoxic damage.

Methods--We treated neural Paju cells with IL-6 and measured the induction of STC-1 mRNA. In addition, we quantified the effect of hypoxic preconditioning on Stc-1 mRNA levels in brains of wild-type and IL-6 deficient mice. Furthermore, we monitored the Stc-1 response in brains of wild-type and transgenic mice, overexpressing IL-6 in the astroglia, before and after induced brain injury.

Results--Hypoxic preconditioning induced an upregulated expression of Stc-1 in brains of wild-type but not of IL-6-deficient mice. Induced brain injury elicited a stronger STC-1 response in brains of transgenic mice, with targeted astroglial IL-6 expression, than in brains of wild-type mice. Moreover, IL-6 induced STC-1 expression via MAPK signaling in neural Paju cells.

Conclusion--These findings indicate that IL-6-mediated expression of STC-1 is one molecular mechanism of hypoxic preconditioning-induced tolerance to brain ischemia.


Key words: hypoxia • IL-6 • ischemia • neuroprotection




This article has been cited by other articles:


Home page
EndocrinologyHome page
A. C.-M. Chang, J. Hook, F. A. Lemckert, M. M. McDonald, M.-A. T. Nguyen, E. C. Hardeman, D. G. Little, P. W. Gunning, and R. R. Reddel
The Murine Stanniocalcin 2 Gene Is a Negative Regulator of Postnatal Growth
Endocrinology, May 1, 2008; 149(5): 2403 - 2410.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Chen, T. J. Maures, H. Jin, J. S. Huo, S. A. Rabbani, J. Schwartz, and C. Carter-Su
SH2B1{beta} (SH2-B{beta}) Enhances Expression of a Subset of Nerve Growth Factor-Regulated Genes Important for Neuronal Differentiation Including Genes Encoding Urokinase Plasminogen Activator Receptor and Matrix Metalloproteinase 3/10
Mol. Endocrinol., February 1, 2008; 22(2): 454 - 476.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. Westberg, M. Serlachius, P. Lankila, and L. C. Andersson
Hypoxic preconditioning induces elevated expression of stanniocalcin-1 in the heart
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1766 - H1771.
[Abstract] [Full Text] [PDF]